Skip to content
Recall Observatory FDA recall evidence

Drug product

Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071

D-0516-2019

February 19, 2019

Class III

Product summary

Firm
Amerigen Pharmaceuticals Inc.
Event
Event 82158
Status
Terminated
Classification
Class III
Quantity
a) 2,413 bottles b) 3,355 bottles
Official record key
drug-enforcement:D-0516-2019

Official wording

Reason: Failed dissolution specifications

Code information: Lot #: a) 18J043A, Exp 09/30/2020, b) 18J043B, Exp 09/30/2020

Distribution pattern: Product was distributed to 4 wholesalers/distributors and 1 retail account who may have further distribute the product throughout the United States.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed dissolution specifications